SCHEMBL18230334

SCHEMBL18230334

N#Cc1sc(NC(=O)c2ccc(C(F)(F)F)s2)nc1-c1ccccn1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 4/20 0.44
▸ MAPT P10636 4/20 0.44
▸ LMNA P02545 4/20 0.44
▸ SMN1; SMN2 Q16637 4/20 0.44
▸ KMT2A Q03164 4/20 0.44
▸ L3MBTL1 Q9Y468 3/20 0.44
▸ HTT P42858 3/20 0.44
▸ MEN1 O00255 3/20 0.44
▸ ALDH1A1 P00352 3/20 0.44
▸ TDP1 Q9NUW8 2/20 0.44
▸ HSP90AA1 P07900 2/20 0.44
▸ ALOX15 P16050 1/20 0.44
▸ ESR1 P03372 1/20 0.44
▸ MDM2 Q00987 1/20 0.44
▸ ADORA2A P29274 3/20 0.43
▸ ADORA1 P30542 2/20 0.43
▸ HDAC3 O15379 1/20 0.40
▸ HDAC4 P56524 1/20 0.40
▸ HDAC1 Q13547 1/20 0.40
▸ HDAC7 Q8WUI4 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18230342 0.85 ADORA2A (0.44) KDM4EMAPTLMNASMN1; SMN2KMT2A
SCHEMBL18230296 0.84 TRPV1 (0.54) KDM4EMAPTLMNASMN1; SMN2KMT2A
SCHEMBL18230321 0.82 ADORA2A (0.48) MAPTLMNASMN1; SMN2HTTALDH1A1
SCHEMBL18230513 0.81 TLR7 (0.49) KDM4EMAPTLMNAALOX15ADORA2A
SCHEMBL18230353 0.81 PTGES (0.49) KDM4EMAPTLMNASMN1; SMN2KMT2A
SCHEMBL18230439 0.80 LMNA (0.53) KDM4EMAPTLMNAKMT2AL3MBTL1
SCHEMBL18230409 0.79 ADORA2A (0.50) MAPTLMNASMN1; SMN2HTTALDH1A1
SCHEMBL18230361 0.79 ADORA3 (0.46) KDM4EMAPTLMNASMN1; SMN2KMT2A
SCHEMBL18230503 0.79 ADORA2A (0.45) MAPTLMNASMN1; SMN2KMT2AHTT
SCHEMBL18230364 0.78 ADORA2A (0.42) KDM4EMAPTSMN1; SMN2KMT2AL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2016183173-A1 ANTIPARASITIC COMPOUNDS Avista Pharma Solutions (US) 2016-11-17 — — WO disclosed
Send feedback